We performed survival analysis on WHO grade 4 glioma patients who had undergone radiotherapy, and the results showed that WHO grade 4 IDH-mutant astrocytoma in both CGGA and TCGA had longer OS and PFS than IDH-wildtype GBM patients. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).